Literature DB >> 1809423

Clinical aspects of depression in chronic pain patients.

R H Dworkin1, M J Gitlin.   

Abstract

It has been widely recognized that an appreciable proportion of chronic pain patients have depressive disorders. Although numerous studies and several literature reviews have examined the relationship between chronic pain and depression, disorders of mood come in many forms, and little attention has been paid to the different types of depressive disorders found among patients with chronic pain. In this article, the different ways in which a chronic pain patient may manifest depression are discussed. Diagnostic criteria for major depression, dysthymia, and atypical depression are described, and the relevance of these disorders and of masked depression to chronic pain is discussed. The medical illnesses and medications that can cause symptoms of depressive disorders are also briefly described. Depressive disorders and their concomitants are an integral part of the experience of chronic pain and are important in developing an optimal treatment plan. For these reasons, they should be carefully evaluated in all patients with chronic pain.

Entities:  

Mesh:

Year:  1991        PMID: 1809423     DOI: 10.1097/00002508-199106000-00004

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  41 in total

1.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

2.  [Two-years' follow-up after lumbar disc surgery.].

Authors:  A Junge; M Fröhlich; S Ahrens; M Hasenbring; D Grob; J Dvorak
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

3.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

4.  AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.

Authors:  Alexander M Le; Michelle Lee; Chen Su; Anthony Zou; Jing Wang
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

5.  Activation of corticostriatal circuitry relieves chronic neuropathic pain.

Authors:  Michelle Lee; Toby R Manders; Sarah E Eberle; Chen Su; James D'amour; Runtao Yang; Hau Yueh Lin; Karl Deisseroth; Robert C Froemke; Jing Wang
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

6.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

7.  Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour.

Authors:  F S Hasnie; V C J Wallace; K Hefner; A Holmes; A S C Rice
Journal:  Br J Anaesth       Date:  2007-05-03       Impact factor: 9.166

8.  Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury.

Authors:  G J Norman; K Karelina; N Zhang; J C Walton; J S Morris; A C Devries
Journal:  Mol Psychiatry       Date:  2009-09-22       Impact factor: 15.992

9.  AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain.

Authors:  Chen Su; Hau Yeuh Lin; Runtao Yang; Duo Xu; Michelle Lee; Natalie Pawlak; Monica Norcini; Alexandra Sideris; Esperanza Recio-Pinto; Dong Huang; Jing Wang
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

10.  Development of Korean Academy of Medical Sciences guideline-rating the impairment in pain.

Authors:  Seong Ho Jang; Ueon Woo Rah; Young Chul Kim; Ye-Soo Park; Daehyun Jo; Yong-Chul Kim
Journal:  J Korean Med Sci       Date:  2009-05-31       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.